Figure 8

Anticancer efficacy of lead compound 11 and doxorubicin (Dox) in 4T1 tumor syngraft model. Two-factor anova statistical analysis was utilized to compare tumor growth between treated groups and the vehicle control (*P < 0.05).
Anticancer efficacy of lead compound 11 and doxorubicin (Dox) in 4T1 tumor syngraft model. Two-factor anova statistical analysis was utilized to compare tumor growth between treated groups and the vehicle control (*P < 0.05).